Last reviewed · How we verify

fast itraconazole tablet — Competitive Intelligence Brief

fast itraconazole tablet (fast itraconazole tablet) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Triazole antifungal. Area: Infectious Disease.

marketed Triazole antifungal Fungal cytochrome P450 lanosterol 14α-demethylase (CYP51) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

fast itraconazole tablet (fast itraconazole tablet) — University of Maryland, Baltimore. Itraconazole is a triazole antifungal that inhibits fungal cytochrome P450-dependent lanosterol 14α-demethylase, disrupting ergosterol synthesis in the fungal cell membrane.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
fast itraconazole tablet TARGET fast itraconazole tablet University of Maryland, Baltimore marketed Triazole antifungal Fungal cytochrome P450 lanosterol 14α-demethylase (CYP51)
Posaconazole Delayed Release Oral Tablet Posaconazole Delayed Release Oral Tablet Cedars-Sinai Medical Center marketed Triazole antifungal Lanosterol 14α-demethylase (CYP51)
Voriconazole low dose Voriconazole low dose Manjunath Prakash Pai marketed Triazole antifungal Lanosterol 14α-demethylase (CYP51)
Voriconazole high dose Voriconazole high dose Manjunath Prakash Pai marketed Triazole antifungal Fungal cytochrome P450 lanosterol 14α-demethylase (CYP51)
anidulafungin and voriconazole anidulafungin and voriconazole Pfizer marketed Echinocandin and triazole antifungal combination β-1,3-glucan synthase (anidulafungin); fungal CYP51/lanosterol 14α-demethylase (voriconazole)
Vfend (voriconazole) tablet Vfend (voriconazole) tablet Seoul National University Hospital marketed Triazole antifungal Cytochrome P450 14α-demethylase (CYP51)
Diflucan (fluconazole) Diflucan (fluconazole) Pfizer marketed Triazole antifungal Fungal cytochrome P450 14α-demethylase (CYP51)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Triazole antifungal class)

  1. University of Maryland, Baltimore · 3 drugs in this class
  2. Manjunath Prakash Pai · 2 drugs in this class
  3. Pfizer · 2 drugs in this class
  4. Janssen Pharmaceutical K.K. · 1 drug in this class
  5. Jiangsu HengRui Medicine Co., Ltd. · 1 drug in this class
  6. Merck Sharp & Dohme LLC · 1 drug in this class
  7. Seoul National University Hospital · 1 drug in this class
  8. University of California, San Francisco · 1 drug in this class
  9. University of Minnesota · 1 drug in this class
  10. Bayer · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). fast itraconazole tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/fast-itraconazole-tablet. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: